• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    1/5/24 9:48:10 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email
    SC 13G/A 1 mlaba10_10524.htm CONESTOGA CAPITAL ADVISORS mlaba10_10524.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 10)*
    MESA LABORATORIES, INC
    (Name of Issuer)
    Common Stock, $0.01 Par Value
    (Title of Class of Securities)
    59064R109
    (CUSIP Number)
    December 31, 2023
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [X] Rule 13d-1(b)
    [   ] Rule 13d-1(c)
    [   ] Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see Instructions).
    CUSIP No.: 59064R109
           
    1
    NAME OF REPORTING PERSON
    Conestoga Capital Advisors LLC
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    23-3072906
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    578,463
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    617,612
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    617,612
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    11.45%
    12
    TYPE OF REPORTING PERSON
    IA
    CUSIP No.: 59064R109
           
    1
    NAME OF REPORTING PERSON
    Conestoga Small Cap Fund
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    22-3865089
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    401,006
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    401,006
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    401,006
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    7.44%
    12
    TYPE OF REPORTING PERSON
    IV
    CUSIP No.: 59064R109
    ITEM 1(a). NAME OF ISSUER:
    MESA LABORATORIES, INC
    ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
    12100 West Sixth Avenue Lakewood, Colorado 80228
    ITEM 2(a). NAME OF PERSON FILING:
    Conestoga Capital Advisors LLC
    Conestoga Small Cap Fund
    ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
    550 E. Swedesford Rd. Suite 120 Wayne, PA 19087
    ITEM 2(c). CITIZENSHIP:
    Delaware
    Delaware
    ITEM 2(d). TITLE OF CLASS OF SECURITIES:
    Common Stock, $0.01 Par Value
    ITEM 2(e). CUSIP NUMBER:
    59064R109
    ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [ ]
    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [X]
    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [X]
    An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f)
    [ ]
    An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g)
    [ ]
    A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h)
    [ ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [ ]
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [ ]
    A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
    (k)
    [ ]
    Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution:
    ITEM 4. OWNERSHIP
    (a) Amount beneficially owned:
    617,612
    401,006
    (b) Percent of class:
    11.45%
    7.44%
    (c) Number of shares as to which the person has:
    (i) sole power to vote or to direct the vote:
    578,463
    401,006

    (ii) shared power to vote or to direct the vote:
    None
    (iii) sole power to dispose or direct the disposition of:
    617,612
    401,006
    (iv) shared power to dispose or to direct the disposition of:
    None
    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
    Not Applicable
    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
    Not Applicable
    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
    Not Applicable
    ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
    Not Applicable
    ITEM 10. CERTIFICATION:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    CUSIP No.: 59064R109
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    January 05 2024
    Conestoga Capital Advisors LLC
    By:
    /s/Duane R. DOrazio
    Name:
    Duane R. DOrazio
    Title:
    Chief Compliance Officer
    Attention — Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    Get the next $MLAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Leadership Updates

    Live Leadership Updates

    See more
    • Mesa Laboratories Appoints Mark Capone to its Board of Directors

      LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa

      1/8/24 8:00:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

      LAKEWOOD, Colo., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company") today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors ("Board"), effective November 3, 2022. Mr. Ladiwala assumes this newly re-created role as an expansion of his current responsibilities on the Board, on which he has served since October 2021. Mr. Ladiwala was selected for this important role due to the thoughtful leadership and contributions he has made to the Board as well as the exceptional breadth of his professional experience. Mr. Ladiwala said, "I am delighted to accept this leadership role on Mes

      11/4/22 3:49:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

      LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the "Board"), effective June 23, 2022. Tony was previously the Executive Vice President and Chief Financial Officer of Corning, Incorporated and retired on May 2, 2022. With Mr. Tripeny's appointment, the Mesa Laboratories, Inc. Board of Directors will be comprised of eight directors, six of whom are independent. Mr. Tripeny is likely to be appointed to the Audit Committee and brings extensive financial experience to the Board. The Board is committed to ongoing director refreshment and continues to consider new, qualified independent

      6/27/22 8:01:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on Mesa Laboratories with a new price target

      Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

      8/28/24 7:48:06 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

      1/4/24 8:29:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    SEC Filings

    See more

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mesa Laboratories Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      6/6/25 3:00:33 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-K filed by Mesa Laboratories Inc.

      10-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:01:28 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:00:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

      LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q25") and full fiscal year ("FY25") ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Revenues increased 5.5%Non-GAAP core organic revenues growth1 was 6.3%Operating income increased 100.5% to $1,469Non-GAAP adjusted operating income ("AOI") excluding unusual items2 decreased 18.0% and was 19.7% as a percentage of revenues   Full FY25 compared to full FY24:

      5/28/25 8:00:16 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Labs Announces Third Quarter Results

      LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter ("3Q25") ended December 31, 2024 (amounts in thousands). Third quarter FY 2025 compared to third quarter FY 2024: Revenues increased 17.5%Non-GAAP core organic revenues1 increase was 13.2%Operating income increased 8,725% to $5,779Non-GAAP adjusted operating income excluding unusual items2 increased 13.3% and was 23.5% as a percentage of revenues We operate our business in four divisions: Sterilization and Disinfection Control ("SDC"

      2/4/25 8:00:38 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Owens Gary M exercised 21,000 shares at a strike of $122.98 and sold $2,602,110 worth of shares (21,000 units at $123.91) (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      3/24/25 1:38:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Director Sullivan John James gifted 2,000 shares, decreasing direct ownership by 7% to 25,878 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      11/25/24 11:40:41 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • President and CEO Owens Gary M was granted 11,559 shares and sold $571,736 worth of shares (5,069 units at $112.79), increasing direct ownership by 18% to 43,337 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      10/29/24 8:18:57 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      10/15/24 1:29:56 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      2/13/24 5:09:39 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      1/23/24 2:18:26 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Financials

    Live finance-specific insights

    See more
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increa

      1/6/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in

      10/2/24 2:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials